Some new research being done in the UK on an obesity medicine has been announced in the press. The research that is being carried out by the famous Imperial College in London will work as an appetite suppressant and has been codenamed PP for now. With the growing obesity problem in the UK the Welcome Trust has pledged some of its millions to sponsor research projects and the development of drugs that can help beat this unhealthy epidemic of fatness.

The PP in the drug’s name stands for pancreatic polypeptide, which is in fact one of the compounds that is released by the human body as a signal for the brain to stop sending eating signals. At present the only way to administer the medicine is by daily injection but this is likely to scare off many potential users and so it is likely that the researchers will continue to look for other ways of delivery for the compound. Possibly the best way would be a pill that would last for a number of days.

The pancreatic polypeptide compound is also produced by the body in people who have benign tumours and it did not seem to harm them in anyway suggesting that to give patients this compound would have no harmful side effects.

The great thing about this compound is that the body produces it naturally and therefore the chances of it causing harmful side effects were less likely. The researchers said that this could be marketed as a natural appetite suppressant and could get the correct approvals from the relevant authorities quickly as a result. The fact that it imitates a natural body process for curbing appetite means that it could be very attractive to dieters and people keen to control their appetites.

So far the problem that has to be overcome is the administration of the medicine as injections would not be commercially popular and the researchers are still looking for a way to sort out this problem. Ukmedix News will be reporting on any new update about this story.